Barrington James · 2 weeks ago
Clinical Trial Manager
Barrington James is a small biotech company seeking a Clinical Trial Manager with a focus on neurology and epilepsy studies. The role involves managing operational delivery of clinical trials from start-up through close-out, ensuring compliance with protocols and regulatory requirements.
Responsibilities
Manage all operational aspects of assigned neurology trials, from start‑up through close‑out, against agreed timelines, budget, and quality standards
Oversee CROs, vendors, and clinical sites, including selection, start‑up, performance oversight, and issue escalation and resolution
Lead development, review, and maintenance of key study documents, including plans, manuals, and training materials
Track study progress, maintain study metrics and risk logs, and provide clear status updates to internal stakeholders
Ensure trials are conducted in accordance with the protocol, ICH‑GCP, and applicable regulatory requirements, supporting audits and inspections as needed
Work closely with clinical, regulatory, data management, and safety colleagues to support patient safety and data integrity
Apply neurology and epilepsy experience to feasibility, site selection, and operational strategy
Qualification
Required
Bachelor's degree in life sciences or a related field; an advanced degree is an advantage
Previous experience as a Clinical Trial Manager with clear responsibility for managing Phase 1–3 studies
Neurology clinical trial experience required; direct experience in epilepsy studies is strongly preferred
Solid understanding of ICH‑GCP and FDA regulations and of standard clinical operations processes
Proven experience overseeing CROs, vendors, and multi‑center trials in a small or lean company setting
Strong communication, organization, and problem‑solving skills, with the ability to work independently and within cross‑functional teams
Preferred
Direct experience in epilepsy studies is strongly preferred
Company
Barrington James
Barrington James has a true global reach, with its international HQ in London-Gatwick, continental hubs in Singapore.
Funding
Current Stage
Growth StageTotal Funding
unknownKey Investors
Orangewood Partners
2022-10-05Private Equity
Recent News
2022-10-14
2022-10-06
Company data provided by crunchbase